PROTAC tau degrader for the treatment of Alzheimer’s disease and primary tauopathies

  • Zhang L
  • Lai Y
  • Lin Y
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Alzheimer's disease (AD) is characterized by progressive decline of

Cite

CITATION STYLE

APA

Zhang, L., Lai, Y., Lin, Y., Lee, M., Lin, S., Hsu, M., … Tempest, P. (2023). PROTAC tau degrader for the treatment of Alzheimer’s disease and primary tauopathies. Alzheimer’s & Dementia, 19(S21). https://doi.org/10.1002/alz.075453

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free